Cargando…
p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins
SIMPLE SUMMARY: The humoral immune response in cancer has been demonstrated to be useful for distinguishing patients from healthy individuals using serum or plasma. Our study aimed to assess whether p53 and p63 proteoforms derived from alternative splicing could have a differential seroreactivity an...
Autores principales: | Montero-Calle, Ana, Garranzo-Asensio, María, Torrente-Rodríguez, Rebeca M., Ruiz-Valdepeñas Montiel, Víctor, Poves, Carmen, Dziaková, Jana, Sanz, Rodrigo, Díaz del Arco, Cristina, Pingarrón, José Manuel, Fernández-Aceñero, María Jesús, Campuzano, Susana, Barderas, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092954/ https://www.ncbi.nlm.nih.gov/pubmed/37046764 http://dx.doi.org/10.3390/cancers15072102 |
Ejemplares similares
-
The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 protein
por: Garranzo-Asensio, María, et al.
Publicado: (2019) -
Electrochemical sensor for rapid determination of fibroblast growth factor receptor 4 in raw cancer cell lysates
por: Torrente-Rodríguez, Rebeca M., et al.
Publicado: (2017) -
Disposable Amperometric Immunosensor for the Determination of Human P53 Protein in Cell Lysates Using Magnetic Micro-Carriers
por: Pedrero, María, et al.
Publicado: (2016) -
Multiplexed monitoring of a novel autoantibody diagnostic signature of colorectal cancer using HaloTag technology-based electrochemical immunosensing platform
por: Garranzo-Asensio, María, et al.
Publicado: (2020) -
First bioelectronic immunoplatform for quantitative secretomic analysis of total and metastasis-driven glycosylated haptoglobin
por: Muñoz-San Martín, Cristina, et al.
Publicado: (2022)